[Predictive value of lipoprotein (a) and apolipoprotein A1 in patients with angiographycally evaluated coronary

José Domingo Sagastagoitia1, Marta Vacas, Yolanda Sáez

  • 1Servicio de Cardiología, Hospital de Basurto, Departamento de Medicina, Universidad del País Vasco UPV/EHU, Bilbao, Vizcaya, España. bdbvarim@lg.ehu.es

Medicina Clinica
|May 26, 2007
PubMed

Insights

High lipoprotein (a) levels are linked to coronary artery obstruction, while high apolipoprotein A1 levels appear protective. This study analyzed lipids, hemostatic, and inflammatory markers in patients with chest pain.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Medicine

Background:

  • Coronary artery stenosis is a major cause of cardiovascular disease.
  • Lipid, hemostatic, and inflammatory markers are implicated in atherosclerosis.
  • Understanding these associations can aid in risk stratification.

Purpose of the Study:

  • To investigate the relationship between blood levels of various biomarkers and the presence of coronary artery stenosis.
  • To identify specific markers associated with coronary obstruction in patients presenting with chest pain.

Main Methods:

  • A cohort of 397 patients with acute chest pain underwent coronary angiography.
  • Blood samples were analyzed for lipids, hemostatic markers (fibrinogen, D-dimer), and inflammatory markers (C-reactive protein, leukocyte count).
  • Logistic regression analysis was used to determine the association between marker levels and coronary obstruction.

Main Results:

  • Patients with coronary stenosis (295) exhibited higher lipoprotein (a), D-dimer, C-reactive protein, and leukocyte counts, along with lower HDL cholesterol and apolipoprotein A1.
  • High lipoprotein (a) levels were significantly associated with coronary obstruction (OR = 2.508).
  • High apolipoprotein A1 levels demonstrated a protective association (OR = 0.472).

Conclusions:

  • Elevated lipoprotein (a) levels are an independent risk factor for coronary obstruction.
  • Higher apolipoprotein A1 levels appear to have a protective effect against coronary artery disease.
  • These findings highlight the potential role of lipoprotein (a) and apolipoprotein A1 in assessing coronary artery disease risk.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...